Perturbation of NCOA6 leads to dilated cardiomyopathy

Cell Rep. 2014 Aug 21;8(4):991-8. doi: 10.1016/j.celrep.2014.07.027. Epub 2014 Aug 14.

Abstract

Dilated cardiomyopathy (DCM) is a progressive heart disease characterized by left ventricular dilation and contractile dysfunction. Although many candidate genes have been identified with mouse models, few of them have been shown to be associated with DCM in humans. Germline depletion of Ncoa6, a nuclear hormone receptor coactivator, leads to embryonic lethality and heart defects. However, it is unclear whether Ncoa6 mutations cause heart diseases in adults. Here, we report that two independent mouse models of NCOA6 dysfunction develop severe DCM with impaired mitochondrial function and reduced activity of peroxisome proliferator-activated receptor δ (PPARδ), an NCOA6 target critical for normal heart function. Sequencing of NCOA6-coding regions revealed three independent nonsynonymous mutations present in 5 of 50 (10%) patients with idiopathic DCM (iDCM). These data suggest that malfunction of NCOA6 can cause DCM in humans.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cardiomyopathy, Dilated / genetics*
  • Cardiomyopathy, Dilated / metabolism
  • Cardiomyopathy, Dilated / pathology
  • Cells, Cultured
  • Gene Knockout Techniques
  • Humans
  • Mice, Transgenic
  • Mitochondria, Heart / physiology
  • Molecular Sequence Data
  • Mutation, Missense
  • Myocardium / metabolism
  • Myocardium / pathology
  • Myocytes, Cardiac / metabolism
  • Nuclear Receptor Coactivators / genetics*
  • Nuclear Receptor Coactivators / metabolism
  • PPAR delta / metabolism
  • Transcription, Genetic

Substances

  • Ncoa6 protein, mouse
  • Nuclear Receptor Coactivators
  • PPAR delta